S. Stallings

发表

Trans-ethnic Meta-analysis and Functional Annotation Illuminates the Genetic Architecture of Fasting Glucose and Insulin.

Xiaofeng Zhu, Todd L Edwards, Dana C Crawford, 2016, American journal of human genetics.

Association of Arrhythmia-Related Genetic Variants With Phenotypes Documented in Electronic Medical Records.

Michael J Ackerman, Joshua C Denny, Dan M Roden, 2016, JAMA.

Design and Anticipated Outcomes of the eMERGE-PGx Project: A Multi-Center Pilot for Pre-Emptive Pharmacogenomics in Electronic Health Record Systems

Suzette J. Bielinski, Christopher G. Chute, Marylyn D. Ritchie, 2014, Clinical pharmacology and therapeutics.

Design and implementation of a massive open online course on enhancing the recruitment of minorities in clinical trials – Faster Together

N. Giuse, Patricia Lee, C. Wilkins, 2021, BMC Medical Research Methodology.

A Multilevel Approach to Stakeholder Engagement in the Formulation of a Clinical Data Research Network

Sarah Stallings, Alecia M. Fair, D. Smoot, 2018, Medical care.

Healthcare provider education to support integration of pharmacogenomics in practice: the eMERGE Network experience.

John J. Connolly, Terrie E. Kitchner, Wendy A. Wolf, 2017, Pharmacogenomics.

Title : A case study evaluating the portability of an executable computable phenotype algorithm across multiple institutions and EHR environments Corresponding

William K. Thompson, Richard C. Kiefer, Eric R. LaRose, 2018 .

Development and validation of the Person-Centeredness of Research Scale

K. Wallston, C. Wilkins, S. Stallings, 2018, Journal of Comparative Effectiveness Research.

An Economic Framework for Evaluating Personalized Medicine

W. Crown, A. Sinskey, S. Finkelstein, 2004 .

Factors influencing precision medicine knowledge and attitudes

Megan C Hollister, Michael L. Williams, C. Wilkins, 2020, bioRxiv.

Development and pilot implementation of guidelines for culturally tailored research recruitment materials for African Americans and Latinos

Sheila V. Kusnoor, Consuelo H. Wilkins, S. Stallings, 2022, BMC Medical Research Methodology.

A framework to evaluate the economic impact of pharmacogenomics.

D. Huse, G. Ginsburg, J. Maguire, 2006, Pharmacogenomics.

Heritability and genome-wide association study of benign prostatic hyperplasia (BPH) in the eMERGE network

H. Hakonarson, D. Roden, G. Hripcsak, 2019, Scientific Reports.

Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials.

Elkan F Halpern, Jeffrey W. Clark, G. Gazelle, 2004, JAMA.

Assessing patient-level knowledge of precision medicine in a community health center setting

M. Aldrich, D. Schlundt, Consuelo H. Wilkins, 2023, Journal of Community Genetics.

Determinants of stage at diagnosis of HPV-related cancer including area deprivation and clinical factors

M. Aldrich, D. V. Velez Edwards, E. Kobetz, 2021, Journal of public health.

Precision Medicine and Health Disparities

M. Lima, C. Wilkins, S. Stallings, 2021 .

Who'll be first? Genomic biomarkers impact on drug discovery and clinical practice.

S. Stallings, 2004, Pharmacogenomics.

Research Networking Systems: The State of Adoption at Institutions Aiming to Augment Translational Research Infrastructure.

David Eichmann, Jihad S Obeid, Layne M. Johnson, 2014, Journal of translational medicine & epidemiology.

A case study evaluating the portability of an executable computable phenotype algorithm across multiple institutions and electronic health record environments

Joshua C. Denny, Jyotishman Pathak, Abel N. Kho, 2018, J. Am. Medical Informatics Assoc..

Determinants of Trustworthiness to Conduct Medical Research: Findings from Focus Groups Conducted with Racially and Ethnically Diverse Adults

E. Bergner, C. Wilkins, S. Stallings, 2020, Journal of General Internal Medicine.

A taxonomy of impacts on clinical and translational research from community stakeholder engagement

C. Wilkins, S. Stallings, L. Novak, 2019, Health expectations : an international journal of public participation in health care and health policy.

The use of disease-modifying new drugs for multiple sclerosis treatment in private-sector health plans.

A. Sinskey, S. Finkelstein, R. Ozminkowski, 2004, Clinical therapeutics.

Concordance between Research Sequencing and Clinical Pharmacogenetic Genotyping in the eMERGE-PGx Study.

H. Hakonarson, T. Manolio, K. Doheny, 2017, The Journal of molecular diagnostics : JMD.

Penetrance of Hemochromatosis in HFE Genotypes Resulting in p.Cys282Tyr and p.[Cys282Tyr];[His63Asp] in the eMERGE Network

Terrie E. Kitchner, Elisha M. Friesema, Marc S. Williams, 2015, American journal of human genetics.

Enrichment sampling for a multi-site patient survey using electronic health records and census data

Sarah C. Stallings, Jonathan S. Schildcrout, Gail P. Jarvik, 2019, J. Am. Medical Informatics Assoc..

Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE network

Melissa A. Basford, John J. Connolly, Terrie E. Kitchner, 2016, Clinical pharmacology and therapeutics.

Patient Stories Can Make a Difference in Patient-Centered Research Design

K. Wallston, Sheba M. George, C. Wilkins, 2020, Journal of patient experience.

Direct2Experts: a pilot national network to demonstrate interoperability among research-networking platforms

Griffin M. Weber, David Eichmann, Maninder K. Kahlon, 2011, J. Am. Medical Informatics Assoc..

Development and Validation of the Perceptions of Research Trustworthiness Scale to Measure Trust Among Minoritized Racial and Ethnic Groups in Biomedical Research in the US

T. Hurd, Consuelo H. Wilkins, S. Stallings, 2022, JAMA network open.

Heritability and genome-wide association study of benign prostatic hyperplasia (BPH) in the eMERGE network

H. Hakonarson, D. Roden, G. Hripcsak, 2019, Scientific Reports.

Conducting a large, multi-site survey about patients’ views on broad consent: challenges and solutions

Jonathan S. Schildcrout, Melissa A. Basford, Stephanie M. Fullerton, 2016, BMC Medical Research Methodology.